Drug and milieu effects with chronic schizophrenics.
D000654:Amobarbital / Q000627:therapeutic use*; D002389:Catatonia / Q000628:therapy*; D008774:Methylphenidate / Q000627:therapeutic use*; D012110:Reserpine / Q000627:therapeutic use*; D012559:Schizophrenia; D014282:Trihexyphenidyl / Q000627:therapeutic use*
D008774:Methylphenidate; D014282:Trihexyphenidyl; D012110:Reserpine; D000654:Amobarbital
AMOBARBITAL/therapeutic use; CATATONIA/therapy; METHYLPHENIDYLACETATE/therapeutic use; RESERPINE/therapeutic use; TRIHEXYPHENIDYL/therapeutic use